Lv2
166 积分 2024-02-15 加入
Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars
18天前
已完结
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy
25天前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
2个月前
已完结
Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification
2个月前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
2个月前
已完结
Idiopathic inflammatory myopathies: current insights and future frontiers
3个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
4个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
4个月前
已完结
Nanoparticles as Novel Drug Delivery Systems for Cancer Treatment: Current Status and Future Perspectives
6个月前
已完结
Recent developments with pH-responsive lyotropic liquid crystalline lipid nanoparticles for targeted bioactive agent delivery
7个月前
已完结
皖公网安备34019202002308
